ZOM Profile
Zomedica Corp., a leading veterinary health company, is dedicated to addressing the specific needs of clinical veterinarians through the development of innovative products for companion animals. The company's flagship product, the TRUFORMA platform, provides advanced point-of-care diagnostic tools designed to detect various disease states in dogs and cats. This platform offers veterinarians rapid and accurate diagnostic capabilities, enhancing their ability to diagnose and treat a wide range of conditions effectively.
In addition to its diagnostic solutions, Zomedica offers the PulseVet system, a cutting-edge technology utilized for the treatment of musculoskeletal issues in both horses and small animals. PulseVet's therapeutic devices are designed to address conditions such as broken bones, tendonitis, and torn ligaments, providing effective relief and promoting healing through non-invasive methods.
The company actively collaborates with industry partners to expand its technological and product offerings. Notably, Zomedica has entered into agreements with Celsee, Inc., focusing on the development and commercialization of liquid biopsy assays and related consumables for cancer detection in companion animals. Additionally, Zomedica is working with Seraph Biosciences, Inc. to develop and market a novel pathogen detection system that aims to improve diagnostic accuracy and pathogen identification in veterinary settings.
Originally established as Zomedica Pharmaceuticals Corp., the company rebranded to Zomedica Corp. in October 2020 to better reflect its focus on veterinary health. Founded in 2015 and headquartered in Ann Arbor, Michigan, Zomedica continues to advance its mission of enhancing veterinary care through innovative technologies and strategic collaborations, solidifying its position as a key player in the veterinary diagnostics and therapeutics market.
|
